Does TREPROSTINIL Cause Infusion site extravasation? 256 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 256 reports of Infusion site extravasation have been filed in association with TREPROSTINIL (TYVASO). This represents 0.3% of all adverse event reports for TREPROSTINIL.
256
Reports of Infusion site extravasation with TREPROSTINIL
0.3%
of all TREPROSTINIL reports
3
Deaths
44
Hospitalizations
How Dangerous Is Infusion site extravasation From TREPROSTINIL?
Of the 256 reports, 3 (1.2%) resulted in death, 44 (17.2%) required hospitalization, and 3 (1.2%) were considered life-threatening.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 256 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
ECULIZUMAB (59)
Which TREPROSTINIL Alternatives Have Lower Infusion site extravasation Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE